The ACS Meeting: Stirring Things Up

The 12,000 or so attendees at the 203rd national American Chemical Society meeting, running April 5-10 in San Francisco, will spend a lot more time discussing purely chemical issues than safety or job concerns; most of the 656 technical meetings, the 6,200 paper presentations, and the 425 expo- sition booths highlight such topics as anticancer drug taxol, plastics recycling, and AIDS prevention. Still, many safety and career topics will be covered. The following are examples: * Aspects of chem

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The 12,000 or so attendees at the 203rd national American Chemical Society meeting, running April 5-10 in San Francisco, will spend a lot more time discussing purely chemical issues than safety or job concerns; most of the 656 technical meetings, the 6,200 paper presentations, and the 425 expo- sition booths highlight such topics as anticancer drug taxol, plastics recycling, and AIDS prevention. Still, many safety and career topics will be covered. The following are examples:

* Aspects of chemical exposure litigation Tuesday, April 7; Marriott hotel A daylong symposium addressing topics including the role of chemist as consultant, and the perspective of a plaintiff in a chemical exposure trial.

* Radiation and society Wednesday, April 8; Sheraton Palace hotel An afternoon focusing on studies of radium dial painters and mortality among employees of the United States Department of Energy.

* Symposium on the chemical education of women in the 1990s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies